Cargando…

Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center

The natural history, prognostication and optimal treatment of Richter transformation developed from chronic lymphocytic leukemia (CLL) are not well defined. We report the clinical characteristics and outcomes of a large series of biopsy-confirmed Richter transformation (diffuse large B-cell lymphoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yucai, Tschautscher, Marcella A., Rabe, Kari G., Call, Timothy G., Leis, Jose F., Kenderian, Saad S., Kay, Neil E., Muchtar, Eli, Van Dyke, Daniel L., Koehler, Amber B., Schwager, Susan M., Slager, Susan L., Parikh, Sameer A., Ding, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049354/ https://www.ncbi.nlm.nih.gov/pubmed/31197071 http://dx.doi.org/10.3324/haematol.2019.224121

Ejemplares similares

The role of (18)F-FDG-PET in detecting Richter transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor
por: Wang, Yucai, et al.
Publicado: (2020)

Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome
por: Wang, Yucai, et al.
Publicado: (2021)

Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index
por: Wang, Yucai, et al.
Publicado: (2021)

The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL
por: Parikh, Sameer A., et al.
Publicado: (2021)

Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia
por: Hampel, Paul J., et al.
Publicado: (2021)

Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
por: Hampel, Paul J., et al.
Publicado: (2022)

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice
por: Parikh, Sameer A., et al.
Publicado: (2020)

Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
por: King, Rebecca L., et al.
Publicado: (2022)

P1094: CHARACTERISTICS, MANAGEMENT, AND OUTCOMES OF PATIENTS WITH T-CELL LARGE GRANULAR LYMPHOCYTIC LEUKEMIA AT A LARGE TERTIARY CARE CENTER
por: Audil, H., et al.
Publicado: (2022)

Secondary Hemophagocytic Syndrome Associated with Richter's Transformation in Chronic Lymphocytic Leukemia
por: El-Haj, Nura, et al.
Publicado: (2014)

Risk of Non-hematologic Cancer in Individuals with High Count Monoclonal B-Cell Lymphocytosis (MBL)
por: Solomon, Benjamin M., et al.
Publicado: (2015)

Sviatoslav Richter
Publicado: (1998)

Sviatoslav Richter.
por: Beethoven, Ludwig van, 1770-1827
Publicado: (1998)

Richter Syndrome
por: Condoluci, Adalgisa, et al.
Publicado: (2021)

P632: COMPARISON OF TREATMENT-EMERGENT ADVERSE EVENTS OF ACALABRUTINIB AND ZANUBRUTINIB IN CLINICAL TRIALS IN B-CELL MALIGNANCIES: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Hwang, Steven, et al.
Publicado: (2023)

Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL
por: Griffin, Rosalie, et al.
Publicado: (2023)

Honouring Burton Richter
Publicado: (2000)

The psychobiology of Curt Richter
Publicado: (1977)

Periorbital Richter Syndrome
por: Gorman, Mark, et al.
Publicado: (2015)

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy
por: Sinha, Sutapa, et al.
Publicado: (2018)

Richter's syndrome: a novel presentation.
por: Smyth, E. F., et al.
Publicado: (2003)

Ibrutinib has some activity in Richter's syndrome
por: Giri, S, et al.
Publicado: (2015)

The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis
por: Parikh, Sameer A., et al.
Publicado: (2022)

Biology and Treatment of Richter Transformation
por: Condoluci, Adalgisa, et al.
Publicado: (2022)

Cytogenomic features of Richter transformation
por: Woroniecka, Renata, et al.
Publicado: (2023)

Rapid and complete response to idelalisib in a case of Richter syndrome
por: Bagacean, Cristina, et al.
Publicado: (2019)

PB1861: ACALABRUTINIB IN THE TREATMENT OF RICHTER SYNDROME
por: Byalik, T., et al.
Publicado: (2022)

Burton Richter à l'honneur
Publicado: (2000)

A Celebration Honoring Burton Richter
por: Collective
Publicado: (2000)

A Case of Richter's Strangulated Hernia
por: Moore, C. A.
Publicado: (1914)

Extranodal Richter's syndrome of the urinary bladder
por: Carrión-Valencia, Almudena, et al.
Publicado: (2018)

Current trends in the management of Richter's syndrome
por: Allan, John N, et al.
Publicado: (2019)

Immunochemotherapy for Richter syndrome: current insights
por: Puła, Bartosz, et al.
Publicado: (2019)

Pembrolizumab in relapsed or refractory Richter syndrome
por: Armand, Philippe, et al.
Publicado: (2020)

Identification of genes involved in alcohol consumption and cigarettes smoking
por: de Andrade, Mariza, et al.
Publicado: (2005)

Associations of history of vaccination and hospitalization due to infection with risk of monoclonal B-cell lymphocytosis
por: Boddicker, Nicholas J., et al.
Publicado: (2022)

Progression and survival of MBL: a screening study of 10 139 individuals
por: Slager, Susan L., et al.
Publicado: (2022)

Sviatoslav Richter plays Scriabin, Debussy, Prokofiev
por: Richter, Sviatoslav, 1915-
Publicado: (1988)

Professors Burton Richter and Samuel Ting at CERN
por: CERN Press Office. Geneva
Publicado: (1976)

Electron Accelerators at CERN -- Prof. Burton Richter
por: CERN. Geneva
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_eh7sclm4vhqkk1o62npo75gku2